Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Coll

Showing results (81-90 of 94) with videos related to

Pageof 10
Sort By:
Nefrologia : Publicacion Oficial De La Sociedad Espanola Nefrologia|April 28, 2009
[Acetate-free on-line PHF: how to improve hyperacetatemia and haemodynamic tolerance]E Coll, R Pérez-García, A L Martín de Francisco, et al.
Parasitology|November 26, 2025
Diversity of obligate ectoparasites and parasitism patterns in wild birds of the Balearic Islands: new chewing lice records for SpainRafael Gutiérrez López, Mikel Alexander González, Julia López-Mercadal, et al.
Bioorganic & Medicinal Chemistry Letters|September 10, 2002
Synthesis and initial SAR studies of 3,6-disubstituted pyrazolo[1,5-a]pyrimidines: a new class of KDR kinase inhibitorsMark E Fraley, William F Hoffman, Robert S Rubino, et al.
Bioorganic & Medicinal Chemistry Letters|March 12, 2004
Design and synthesis of 3,7-diarylimidazopyridines as inhibitors of the VEGF-receptor KDRZhicai Wu, Mark E Fraley, Mark T Bilodeau, et al.
Bioorganic & Medicinal Chemistry Letters|July 11, 2003
Design and synthesis of 1,5-diarylbenzimidazoles as inhibitors of the VEGF-receptor KDRMark T Bilodeau, April M Cunningham, Timothy J Koester, et al.
Bioorganic & Medicinal Chemistry Letters|May 6, 2004
The discovery of N-(1,3-thiazol-2-yl)pyridin-2-amines as potent inhibitors of KDR kinaseMark T Bilodeau, Leonard D Rodman, Georgia B McGaughey, et al.
Langenbeck'S Archives of Surgery|April 30, 2013
Could 18F-FDG-PET/CT avoid unnecessary thyroidectomies in patients with cytological diagnosis of follicular neoplasm?N Muñoz Pérez, J M Villar del Moral, M A Muros Fuentes, et al.
Bioorganic & Medicinal Chemistry Letters|December 31, 2003
Optimization of the indolyl quinolinone class of KDR (VEGFR-2) kinase inhibitors: effects of 5-amido- and 5-sulphonamido-indolyl groups on pharmacokinetics and hERG bindingMark E Fraley, Kenneth L Arrington, Carolyn A Buser, et al.
Bioorganic & Medicinal Chemistry Letters|November 22, 2002
Optimization of a pyrazolo[1,5-a]pyrimidine class of KDR kinase inhibitors: improvements in physical properties enhance cellular activity and pharmacokineticsMark E Fraley, Robert S Rubino, William F Hoffman, et al.
Bioorganic & Medicinal Chemistry Letters|August 28, 2003
Discovery and evaluation of 3-(5-thien-3-ylpyridin-3-yl)-1H-indoles as a novel class of KDR kinase inhibitorsMark E Fraley, Kenneth L Arrington, Scott R Hambaugh, et al.
Pageof 10

Showing results (81-90 of 94) with videos related to

Sort By:
Pageof 10
Nefrologia : Publicacion Oficial De La Sociedad Espanola Nefrologia|April 28, 2009
[Acetate-free on-line PHF: how to improve hyperacetatemia and haemodynamic tolerance]E Coll, R Pérez-García, A L Martín de Francisco, et al.
Parasitology|November 26, 2025
Diversity of obligate ectoparasites and parasitism patterns in wild birds of the Balearic Islands: new chewing lice records for SpainRafael Gutiérrez López, Mikel Alexander González, Julia López-Mercadal, et al.
Bioorganic & Medicinal Chemistry Letters|September 10, 2002
Synthesis and initial SAR studies of 3,6-disubstituted pyrazolo[1,5-a]pyrimidines: a new class of KDR kinase inhibitorsMark E Fraley, William F Hoffman, Robert S Rubino, et al.
Bioorganic & Medicinal Chemistry Letters|March 12, 2004
Design and synthesis of 3,7-diarylimidazopyridines as inhibitors of the VEGF-receptor KDRZhicai Wu, Mark E Fraley, Mark T Bilodeau, et al.
Bioorganic & Medicinal Chemistry Letters|July 11, 2003
Design and synthesis of 1,5-diarylbenzimidazoles as inhibitors of the VEGF-receptor KDRMark T Bilodeau, April M Cunningham, Timothy J Koester, et al.
Bioorganic & Medicinal Chemistry Letters|May 6, 2004
The discovery of N-(1,3-thiazol-2-yl)pyridin-2-amines as potent inhibitors of KDR kinaseMark T Bilodeau, Leonard D Rodman, Georgia B McGaughey, et al.
Langenbeck'S Archives of Surgery|April 30, 2013
Could 18F-FDG-PET/CT avoid unnecessary thyroidectomies in patients with cytological diagnosis of follicular neoplasm?N Muñoz Pérez, J M Villar del Moral, M A Muros Fuentes, et al.
Bioorganic & Medicinal Chemistry Letters|December 31, 2003
Optimization of the indolyl quinolinone class of KDR (VEGFR-2) kinase inhibitors: effects of 5-amido- and 5-sulphonamido-indolyl groups on pharmacokinetics and hERG bindingMark E Fraley, Kenneth L Arrington, Carolyn A Buser, et al.
Bioorganic & Medicinal Chemistry Letters|November 22, 2002
Optimization of a pyrazolo[1,5-a]pyrimidine class of KDR kinase inhibitors: improvements in physical properties enhance cellular activity and pharmacokineticsMark E Fraley, Robert S Rubino, William F Hoffman, et al.
Bioorganic & Medicinal Chemistry Letters|August 28, 2003
Discovery and evaluation of 3-(5-thien-3-ylpyridin-3-yl)-1H-indoles as a novel class of KDR kinase inhibitorsMark E Fraley, Kenneth L Arrington, Scott R Hambaugh, et al.
Pageof 10